195 related articles for article (PubMed ID: 37042969)
1. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
[TBL] [Abstract][Full Text] [Related]
2. The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Li JX; Chiang CC; Chen SN; Lin JM; Tsai YY
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497759
[TBL] [Abstract][Full Text] [Related]
3. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.
Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
Digestion; 2023; 104(4):328-334. PubMed ID: 36893744
[TBL] [Abstract][Full Text] [Related]
5. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.
Singh B; Kedia S; Konijeti G; Mouli VP; Dhingra R; Kurrey L; Srivastava S; Pradhan R; Makharia G; Ahuja V
Indian J Gastroenterol; 2015 Jan; 34(1):43-50. PubMed ID: 25663290
[TBL] [Abstract][Full Text] [Related]
6. Dermatologic manifestations in pediatric patients with inflammatory bowel disease.
Afarideh M; Bartoletta K; Tollefson MM
Pediatr Dermatol; 2024; 41(2):234-242. PubMed ID: 38326222
[TBL] [Abstract][Full Text] [Related]
7. What are the risk factors for extraintestinal manifestations in inflammatory bowel diseases?
Yeo MK; Park JH; Kang SH; Moon HS; Sung JK; Jeong HY; Kim JS
Medicine (Baltimore); 2023 Mar; 102(9):e33031. PubMed ID: 36862909
[TBL] [Abstract][Full Text] [Related]
8. [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis].
Mendoza JL; Lana R; Taxonera C; Alba C; Izquierdo S; Díaz-Rubio M
Med Clin (Barc); 2005 Sep; 125(8):297-300. PubMed ID: 16159555
[TBL] [Abstract][Full Text] [Related]
9. Differences in the prevalence of uveitis between Crohn's disease and ulcerative colitis: A systematic review and meta-analysis.
Lin H; Zhang J; Liang C; Wu D; Tan Y; Luo L; Liu Z
Acta Ophthalmol; 2024 Jun; 102(4):e485-e492. PubMed ID: 37830172
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.
He R; Zhao S; Cui M; Chen Y; Ma J; Li J; Wang X
Front Immunol; 2023; 14():1234535. PubMed ID: 37954590
[TBL] [Abstract][Full Text] [Related]
11. [Inflammatory bowel diseases: Transformation of representations. A review].
Maev IV; Bakulin IG; Skalinskaya MI; Skazyvaeva EV
Ter Arkh; 2023 Dec; 95(12):1064-1074. PubMed ID: 38158940
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn's disease) in Spain: A Systematic Review.
Barreiro-de Acosta M; Molero A; Artime E; Díaz-Cerezo S; Lizán L; de Paz HD; Martín-Arranz MD
Adv Ther; 2023 May; 40(5):1975-2014. PubMed ID: 36928496
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Shen Z; Zhang M; Liu Y; Ge C; Lu Y; Shen H; Zhu L
BMJ Open; 2024 Mar; 14(3):e074659. PubMed ID: 38453206
[TBL] [Abstract][Full Text] [Related]
15. Association between inflammatory bowel disease and subsequent depression or anxiety disorders - A retrospective cohort study of 31,728 outpatients.
Roderburg C; Yaqubi K; Konrad M; May P; Luedde T; Kostev K; Loosen SH
J Psychiatr Res; 2024 Jan; 169():231-237. PubMed ID: 38048672
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
17. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation.
Kappelman MD; Farkas DK; Long MD; Erichsen R; Sandler RS; Sørensen HT; Baron JA
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):265-73.e1. PubMed ID: 23602821
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations in inflammatory bowel disease.
Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
[TBL] [Abstract][Full Text] [Related]
19. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.
Zippi M; Corrado C; Pica R; Avallone EV; Cassieri C; De Nitto D; Paoluzi P; Vernia P
World J Gastroenterol; 2014 Dec; 20(46):17463-7. PubMed ID: 25516659
[TBL] [Abstract][Full Text] [Related]
20. Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Fedor I; Zold E; Barta Z
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
